Skip to Content

EU regulator evaluating Moderna shot for children ages 5-11


AMSTERDAM (AP) — The European Union’s drug regulator says it has started evaluating whether to authorize Moderna’s COVID-19 vaccine for children ages 5 to 11. The Amsterdam-based European Medicines Agency already is evaluating the vaccine made by Pfizer-BioNTech for use in the 5-11 age group. In a statement on Wednesday, the EMA said it anticipates making a recommendation about Moderna’s vaccine in about two months, unless more data or analysis is needed. The decision could significantly open up COVID-19 vaccination across the continent for young children. The coronavirus vaccines made by Moderna and Pfizer-BioNTech have already been cleared for use in children ages 12 to 17 in Europe, where new coronavirus infections have increased for six weeks.

Article Topic Follows: AP National Business

Jump to comments ↓

Author Profile Photo

Associated Press


KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content